RSC-57 for Kabuki Syndrome Receives Orphan Drug and Rare Pediatric Disease Designations
Just over a week ago, drug discovery and development company Rescindo Therapeutics Inc. ("Rescindo") shared that its drug candidate RSC-57 received both Orphan Drug and Rare Pediatric Disease designations. The…